Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.749 Q1 | 254 | 22 | 53 | 9201 | 1078 | 52 | 19.59 | 418.23 | |
2 | Pharmacology and Therapeutics | journal | 3.872 Q1 | 233 | 103 | 307 | 22992 | 3285 | 304 | 9.97 | 223.22 | |
3 | Food and Drug Law Journal | journal | 0.329 Q3 | 23 | 35 | 117 | 7167 | 62 | 117 | 0.57 | 204.77 | |
4 | Open Neuropsychopharmacology Journal | journal | 0.173 Q3 | 6 | 1 | 12 | 203 | 4 | 11 | 0.33 | 203.00 | |
5 | Medicinal Research Reviews | journal | 2.961 Q1 | 150 | 25 | 88 | 4452 | 878 | 87 | 10.10 | 178.08 | |
6 | Annual Review of Pharmacology and Toxicology | journal | 12.860 Q1 | 224 | 17 | 66 | 2944 | 1683 | 66 | 20.98 | 173.18 | |
7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.552 Q1 | 82 | 11 | 38 | 1827 | 176 | 38 | 3.84 | 166.09 | |
8 | Advances in Molecular Toxicology | book series | 0.153 Q4 | 18 | 8 | 16 | 1244 | 6 | 14 | 0.38 | 155.50 | |
9 | Current Medicinal Chemistry | journal | 1.700 Q1 | 202 | 289 | 800 | 38208 | 4319 | 799 | 5.25 | 132.21 | |
10 | Drug Resistance Updates | journal | 5.328 Q1 | 132 | 19 | 49 | 2423 | 644 | 49 | 13.41 | 127.53 | |
11 | Current Molecular Pharmacology | journal | 0.690 Q2 | 49 | 14 | 50 | 1728 | 117 | 50 | 2.34 | 123.43 | |
12 | CNS and Neurological Disorders - Drug Targets | journal | 1.846 Q1 | 96 | 86 | 147 | 10049 | 656 | 130 | 3.62 | 116.85 | |
13 | Advances in Pharmacology | journal | 1.013 Q2 | 86 | 42 | 45 | 4899 | 108 | 38 | 1.55 | 116.64 | |
14 | Pharmacogenomics and Personalized Medicine | journal | 0.126 Q4 | 37 | 11 | 9 | 1260 | 3 | 9 | 0.33 | 114.55 | |
15 | Current Neuropharmacology | journal | 1.271 Q1 | 103 | 41 | 88 | 4630 | 324 | 85 | 3.46 | 112.93 | |
16 | Current Pharmaceutical Design | journal | 1.657 Q1 | 183 | 409 | 1056 | 45111 | 4994 | 943 | 4.85 | 110.30 | |
17 | Current Vascular Pharmacology | journal | 1.040 Q2 | 69 | 87 | 128 | 9547 | 458 | 119 | 3.67 | 109.74 | |
18 | Pharmakeftiki | journal | 0.101 Q4 | 6 | 2 | 29 | 219 | 0 | 28 | 0.00 | 109.50 | |
19 | Current Drug Metabolism | journal | 1.247 Q1 | 122 | 73 | 280 | 7949 | 1367 | 265 | 4.58 | 108.89 | |
20 | Current Drug Targets | journal | 1.356 Q1 | 119 | 159 | 397 | 17091 | 1370 | 355 | 3.09 | 107.49 | |
21 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 | |
22 | Anti-Infective Agents | journal | 0.321 Q3 | 26 | 18 | 74 | 1885 | 73 | 71 | 0.98 | 104.72 | |
23 | Progress in Medicinal Chemistry | journal | 0.769 Q2 | 38 | 6 | 27 | 624 | 45 | 21 | 1.59 | 104.00 | |
24 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
25 | Open Pharmacology Journal | journal | 0.131 Q4 | 6 | 4 | 5 | 400 | 2 | 5 | 0.40 | 100.00 | |
26 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 107 | 402 | 10462 | 1269 | 401 | 2.93 | 97.78 | |
27 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.148 Q4 | 27 | 37 | 109 | 3601 | 32 | 98 | 0.24 | 97.32 | |
28 | Inflammation and Allergy - Drug Targets | journal | 1.004 Q2 | 55 | 43 | 116 | 4170 | 408 | 113 | 3.51 | 96.98 | |
29 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.705 Q2 | 45 | 34 | 95 | 3265 | 206 | 93 | 1.95 | 96.03 | |
30 | Neurotherapeutics | journal | 2.320 Q1 | 136 | 53 | 220 | 4993 | 1477 | 206 | 6.90 | 94.21 | |
31 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 156 | 4867 | 5 | 102 | 0.03 | 93.60 | |
32 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.842 Q2 | 43 | 20 | 100 | 1852 | 268 | 99 | 2.86 | 92.60 | |
33 | Cellular and Molecular Life Sciences | journal | 4.001 Q1 | 261 | 303 | 884 | 27854 | 6291 | 873 | 7.30 | 91.93 | |
34 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.178 Q3 | 17 | 18 | 113 | 1632 | 45 | 102 | 0.39 | 90.67 | |
35 | Open Medicinal Chemistry Journal | journal | 0.121 Q4 | 23 | 6 | 1 | 539 | 0 | 1 | 0.00 | 89.83 | |
36 | Expert Opinion on Biological Therapy | journal | 1.256 Q1 | 102 | 147 | 477 | 12860 | 1755 | 468 | 3.73 | 87.48 | |
37 | HIV Therapy | journal | 0.260 Q3 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | |
38 | Infectious Disorders - Drug Targets | journal | 0.876 Q2 | 61 | 44 | 122 | 3794 | 309 | 107 | 2.28 | 86.23 | |
39 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.354 Q1 | 108 | 86 | 228 | 7351 | 984 | 208 | 4.00 | 85.48 | |
40 | Current Pharmacogenomics and Personalized Medicine | journal | 0.281 Q3 | 20 | 32 | 53 | 2735 | 60 | 48 | 1.13 | 85.47 | |
41 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.043 Q2 | 100 | 121 | 315 | 10240 | 1249 | 310 | 3.82 | 84.63 | |
42 | CNS Neuroscience and Therapeutics | journal | 1.013 Q2 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
43 | Journal of NeuroImmune Pharmacology | journal | 1.344 Q1 | 91 | 55 | 126 | 4586 | 441 | 119 | 3.48 | 83.38 | |
44 | Expert Opinion on Therapeutic Patents | journal | 0.687 Q2 | 88 | 118 | 324 | 9662 | 668 | 316 | 2.63 | 81.88 | |
45 | Journal of Receptor, Ligand and Channel Research | journal | 13 | 5 | 0 | 399 | 0 | 0 | 0.00 | 79.80 | ||
46 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
47 | Current Radiopharmaceuticals | journal | 0.245 Q3 | 32 | 22 | 33 | 1723 | 25 | 30 | 0.76 | 78.32 | |
48 | Journal of International Peacekeeping | journal | 0.137 Q4 | 14 | 18 | 49 | 1393 | 13 | 46 | 0.48 | 77.39 | |
49 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
50 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®